慢性B型主动脉夹层中抗高血压药物依从性是管理争议中的重要考量
该横断面混合方法研究纳入47例慢性B型主动脉夹层患者,采用8项Morisky药物依从性量表评估抗高血压药物依从性。结果显示20例(43%)依从性高、17例(36%)中等、10例(21%)低;既往主动脉手术、服药数量多、感知治疗获益、记忆力好及副作用恐惧低与更高依从性相关。作者认为医疗管理仍是无并发症TBAD的主要治疗,但多数患者依从性差,影响两种策略的可靠比较。
要点
- 47例慢性B型主动脉夹层患者中,仅43%报告高依从性,21%报告低依从性。
- 既往主动脉手术、服药数量多、感知获益、记忆力好及副作用恐惧低与更高依从性相关。
- 作者认为医疗管理仍是无并发症TBAD的主要治疗,但多数患者依从性差。
核心结论
- 医疗管理仍是无并发症慢性B型主动脉夹层的主要治疗,但多数患者对抗高血压药物依从性差。
- 作者认为依从性差是胸主动脉腔内修复术争议中的重要因素,当治疗组中约半数患者可能未接受既定干预时,无法可靠比较两种策略。
- 作者提出需进一步开展工作改善药物依从性并理解其对疾病进展的影响,以促进争议解决和患者最佳结局。
研究设计与样本
- 横断面混合方法研究,纳入47例慢性B型主动脉夹层患者,来自三级血管单位。
- 采用8项Morisky药物依从性量表评估药物依从性,同时评估人口学、行为、心理变量及疾病特异性知识。
主要发现
- 患者平均年龄59岁,男性占81%;平均总服药数量为5.8种(范围2-14),平均抗高血压药物数量为1.9种(范围1-6)。
- 47例患者中,20例(43%)报告高依从性,17例(36%)报告中等依从性,10例(21%)报告低依从性。
- 既往主动脉手术与更高依从性相关(β=0.332;P=.03)。
- 服药数量更多与更高依从性相关(β=0.332;P=.026)。
- 感知治疗获益(β=0.486;P<.001)、记忆力好(β=0.579;P<.001)及副作用恐惧低(β=0.272;P=.014)与更高依从性相关。
关键数值与推荐
- 高依从性:20例(43%);中等依从性:17例(36%);低依从性:10例(21%)。
- 既往主动脉手术与依从性相关:β=0.332;P=.03。
- 服药数量更多与依从性相关:β=0.332;P=.026。
- 感知治疗获益与依从性相关:β=0.486;P<.001。
- 记忆力好与依从性相关:β=0.579;P<.001;副作用恐惧低与依从性相关:β=0.272;P=.014。
临床怎么用
- 原文未据此给出推荐。
- 作者认为医疗管理仍是无并发症慢性B型主动脉夹层的主要治疗,但多数患者依从性差。
- 作者认为依从性差是胸主动脉腔内修复术争议中的重要因素,无法在治疗组约半数患者可能未接受既定干预时可靠比较两种策略。
- 作者提出需进一步开展工作改善药物依从性并理解其对疾病进展的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Early aortic stenting in chronic type B aortic dissection (TBAD) may lead to long-term benefit, although the optimal treatment strategy is hotly debated. A robust comparison to outcomes seen in medically managed patients is challenging as the rate of antihypertensive medication adherence is unknown. The aims of this study were therefore to identify the rate of antihypertensive medication adherence and predictors of adherence in TBAD. METHODS: This was a cross-sectional mixed methods study of patients with TBAD. Medication adherence was assessed by the eight-item Morisky Medication Adherence Scale together with an assessment of demographic, behavioral, and psychological variables and disease-specific knowledge. RESULTS: There were 47 patients (mean age, 59 years; 81% male) who were recruited from a tertiary vascular unit. The mean total number of medications taken was 5.8 (2-14), and the mean number of antihypertensive medications was 1.9 (1-6). Of the 47 patients, 20 (43%) reported high levels of medication adherence, 17 (36%) reported moderate adherence, and 10 (21%) reported low adherence. Previous aortic surgery was associated with higher levels of adherence (β = 0.332; P = .03), as was taking a greater number of medications (β = 0.332; P = .026), perceived benefit from treatment (β = 0.486; P < .001), good memory (β = 0.579; P < .001), and low fears of side effects (β = 0.272; P < .014). CONCLUSIONS: Medical management remains the mainstay of treatment in uncomplicated TBAD; however, the majority of patients are poorly adherent to their antihypertensive medications. The merits of thoracic endovascular aortic repair in TBAD are argued, and poor adherence is an important factor in the debate; one cannot robustly compare two strategies when half of a treatment group may not be receiving the stated intervention. To develop an evidence-based treatment strategy for TBAD, we must take into account the direct and indirect effects of medical therapy and thoracic endovascular aortic repair. Further work to improve medication adherence and to understand its impact on disease progression is vital to inform the debate and to deliver the best outcomes for patients.
引用
- Martin G, Patel N, Grant Y, et al. Antihypertensive medication adherence in chronic type B aortic dissection is an important consideration in the management debate. J Vasc Surg. 2018. PMID: 29615356. doi:10.1016/j.jvs.2017.12.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。